INCY Incyte
Nasdaq · SEC CIK 879169 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $58.34M 30 sales by 10 insiders
- Filings on record
- 440 since 2021-07-02, latest 2026-09-24 16:06
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Hoppenot Herve | Dir | — | $19.77M |
| CAGNONI PABLO J | Pres, R, D | — | $14.10M |
| Stein Steven H | EVP, Chief Medical Off | — | $7.86M |
| Mayes Patrick A | EVP, CSO | — | $6.56M |
| Morrissey Michael James | EVP, Head of Tech. Ops | — | $5.68M |
| Clancy Paul J | Dir | — | $1.42M |
| Issa Mohamed Khairie | EVP, Head of US Oncology | — | $1.31M |
| Tray Thomas | Principal Accounting Off | — | $879.0K |
| Denton Sheila A. | EVP, GC | — | $465.2K |
| Heeson Lee | EVP, Head of Incyte Intl | — | $289.0K |
Transactions 497
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-17 | 2025-10-15 | INCY | Denton Sheila A. | EVP, GC | M - OptEx | $64.25 | +277 | 26.8K | +1% | +$17.8K |
| D | 2025-10-06 | 2025-10-02 | INCY | Denton Sheila A. | EVP, GC | M - OptEx | $58.06 | +599 | 33.8K | +2% | +$34.8K |
| DM | 2025-10-06 | 2025-10-02+ | INCY | Denton Sheila A. | EVP, GC | S - Sale+OE | $85.85 | -4,100 | 33.2K | -11% | -$352.0K |
| D | 2025-10-06 | 2025-10-02 | INCY | Denton Sheila A. | EVP, GC | F - Tax | $86.28 | -3,130 | 30.1K | -9% | -$270.1K |
| 2025-10-03 | 2025-10-01 | INCY | Mayes Patrick A | EVP, CSO | F - Tax | $86.70 | -1,569 | 65.8K | -2% | -$136.0K | |
| 2025-10-03 | 2025-10-01 | INCY | Heeson Lee | EVP, Head of Incyte Intl | F - Tax | $86.70 | -463 | 32.3K | -1% | -$40.1K | |
| MI | 2025-10-02 | 2025-09-30 | INCY | BAKER FELIX | Dir, 10% | A - Grant | $0.00 | +776 | 2.82M | +0.0% | $0 |
| 2025-10-02 | 2025-09-30 | INCY | Clancy Paul J | Dir | A - Grant | $84.81 | +285 | 23.2K | +1% | +$24.2K | |
| 2025-10-02 | 2025-09-30 | INCY | HARRIGAN EDMUND | Dir | A - Grant | $84.81 | +289 | 20.6K | +1% | +$24.5K | |
| D | 2025-09-24 | 2025-09-22 | INCY | Gardner David H | EVP, Chief Strategy Off | A - Grant | $0.00 | +9,429 | 9,429 | New | $0 |
| D | 2025-09-18 | 2025-09-16 | INCY | Denton Sheila A. | EVP, GC | M - OptEx | $64.25 | +278 | 33.5K | +0.8% | +$17.9K |
| D | 2025-09-18 | 2025-09-16 | INCY | Denton Sheila A. | EVP, GC | S - Sale+OE | $83.15 | -278 | 33.2K | -0.8% | -$23.1K |
| D | 2025-09-04 | 2025-09-02 | INCY | Denton Sheila A. | EVP, GC | S - Sale+OE | $84.97 | -598 | 33.2K | -2% | -$50.8K |
| D | 2025-09-04 | 2025-09-02 | INCY | Denton Sheila A. | EVP, GC | M - OptEx | $58.06 | +598 | 33.8K | +2% | +$34.7K |
| D | 2025-08-27 | 2025-08-25 | INCY | Basi Ramitpal K | EVP, Human Resources | A - Grant | $0.00 | +6,506 | 6,506 | New | $0 |
| D | 2025-08-19 | 2025-08-15 | INCY | Denton Sheila A. | EVP, GC | S - Sale+OE | $86.81 | -277 | 33.2K | -0.8% | -$24.0K |
| D | 2025-08-19 | 2025-08-15 | INCY | Denton Sheila A. | EVP, GC | M - OptEx | $64.25 | +277 | 33.5K | +0.8% | +$17.8K |
| D | 2025-08-06 | 2025-08-04 | INCY | Denton Sheila A. | EVP, GC | M - OptEx | $58.06 | +598 | 33.8K | +2% | +$34.7K |
| D | 2025-08-06 | 2025-08-04 | INCY | Denton Sheila A. | EVP, GC | S - Sale+OE | $75.77 | -598 | 33.2K | -2% | -$45.3K |
| 2025-07-23 | 2025-07-21 | INCY | Stein Steven H | EVP, Chief Medical Off | S - Sale | $67.94 | -3,706 | 102.9K | -3% | -$251.8K | |
| DM | 2025-07-17 | 2025-07-15+ | INCY | Denton Sheila A. | EVP, GC | S - Sale+OE | $69.57 | -4,115 | 33.2K | -11% | -$286.3K |
| D | 2025-07-17 | 2025-07-15 | INCY | Denton Sheila A. | EVP, GC | A - Grant | $0.00 | +8,184 | 34.0K | +32% | $0 |
| D | 2025-07-17 | 2025-07-15 | INCY | Denton Sheila A. | EVP, GC | M - OptEx | $64.25 | +3,330 | 29.8K | +13% | +$214.0K |
| D | 2025-07-17 | 2025-07-15 | INCY | Denton Sheila A. | EVP, GC | F - Tax | $68.25 | -703 | 25.8K | -3% | -$48.0K |
| 2025-07-17 | 2025-07-16 | INCY | Iyengar Vijay K | EVP, GMAPPS | S - Sale | $68.36 | -983 | 40.5K | -2% | -$67.2K | |
| D | 2025-07-17 | 2025-07-15 | INCY | Trotta Matteo | EVP, GM, Dermatology US | A - Grant | $0.00 | +5,261 | 15.0K | +54% | $0 |
| D | 2025-07-17 | 2025-07-15 | INCY | Trotta Matteo | EVP, GM, Dermatology US | F - Tax | $68.25 | -182 | 9,755 | -2% | -$12.4K |
| D | 2025-07-17 | 2025-07-15 | INCY | Issa Mohamed Khairie | EVP, Head of US Oncology | A - Grant | $0.00 | +8,769 | 85.3K | +11% | $0 |
| 2025-07-17 | 2025-07-16 | INCY | Flannelly Barry P | EVP, General Manager US | S - Sale | $68.36 | -1,340 | 35.1K | -4% | -$91.6K | |
| DM | 2025-07-16 | 2025-07-14+ | INCY | SWAIN PAULA J | EVP, Human Resources | F - Tax | $69.01 | -1,007 | 100.1K | -1.0% | -$69.5K |
| D | 2025-07-16 | 2025-07-15 | INCY | SWAIN PAULA J | EVP, Human Resources | A - Grant | $0.00 | +6,430 | 106.5K | +6% | $0 |
| 2025-07-16 | 2025-07-15 | INCY | Flannelly Barry P | EVP, General Manager US | S - Sale | $69.86 | -1,192 | 37.6K | -3% | -$83.3K | |
| M | 2025-07-16 | 2025-07-14+ | INCY | Flannelly Barry P | EVP, General Manager US | F - Tax | $69.02 | -2,063 | 36.5K | -5% | -$142.4K |
| DM | 2025-07-16 | 2025-07-14+ | INCY | Stein Steven H | EVP, Chief Medical Off | F - Tax | $69.10 | -3,151 | 94.3K | -3% | -$217.7K |
| D | 2025-07-16 | 2025-07-14 | INCY | Stein Steven H | EVP, Chief Medical Off | S - Sale | $68.47 | -15.0K | 97.5K | -13% | -$1.02M |
| D | 2025-07-16 | 2025-07-15 | INCY | Stein Steven H | EVP, Chief Medical Off | A - Grant | $0.00 | +12.3K | 106.6K | +13% | $0 |
| DM | 2025-07-16 | 2025-07-14+ | INCY | Stamoulis Christiana | EVP, CFO | F - Tax | $69.10 | -2,852 | 114.7K | -2% | -$197.1K |
| D | 2025-07-16 | 2025-07-15 | INCY | Stamoulis Christiana | EVP, CFO | A - Grant | $0.00 | +11.1K | 125.8K | +10% | $0 |
| DM | 2025-07-16 | 2025-07-14+ | INCY | Tray Thomas | Principal Accounting Off | F - Tax | $69.19 | -1,275 | 19.8K | -6% | -$88.2K |
| D | 2025-07-16 | 2025-07-15 | INCY | Tray Thomas | Principal Accounting Off | A - Grant | $0.00 | +4,482 | 24.3K | +23% | $0 |
| M | 2025-07-16 | 2025-07-14+ | INCY | Hoppenot Herve | Special Advisor to the CEO, Dir | F - Tax | $69.14 | -9,674 | 517.1K | -2% | -$668.8K |
| D | 2025-07-16 | 2025-07-15 | INCY | CAGNONI PABLO J | Pres, R, D | A - Grant | $0.00 | +17.5K | 234.8K | +8% | $0 |
| DM | 2025-07-16 | 2025-07-14+ | INCY | CAGNONI PABLO J | Pres, R, D | F - Tax | $68.82 | -3,908 | 219.9K | -2% | -$268.9K |
| DM | 2025-07-16 | 2025-07-14+ | INCY | Iyengar Vijay K | EVP, GMAPPS | F - Tax | $68.97 | -1,431 | 35.1K | -4% | -$98.7K |
| D | 2025-07-16 | 2025-07-15 | INCY | Iyengar Vijay K | EVP, GMAPPS | S - Sale | $69.86 | -1,177 | 35.9K | -3% | -$82.2K |
| D | 2025-07-16 | 2025-07-15 | INCY | Iyengar Vijay K | EVP, GMAPPS | A - Grant | $0.00 | +6,430 | 41.5K | +18% | $0 |
| 2025-07-07 | 2025-07-02 | INCY | SWAIN PAULA J | EVP, Human Resources | F - Tax | $68.17 | -6,285 | 101.1K | -6% | -$428.4K | |
| 2025-07-07 | 2025-07-02 | INCY | Tray Thomas | Principal Accounting Off | F - Tax | $68.17 | -897 | 21.1K | -4% | -$61.1K | |
| 2025-07-07 | 2025-07-02 | INCY | Hoppenot Herve | Special Advisor to the CEO, Dir | F - Tax | $68.17 | -42.8K | 526.8K | -8% | -$2.92M | |
| 2025-07-07 | 2025-07-02 | INCY | Iyengar Vijay K | EVP, GMAPPS | F - Tax | $68.17 | -6,809 | 46.3K | -13% | -$464.2K | |
| M | 2025-07-07 | 2025-07-03 | INCY | Iyengar Vijay K | EVP, GMAPPS | S - Sale | $68.15 | -8,617 | 37.7K | -19% | -$587.3K |
| 2025-07-07 | 2025-07-02 | INCY | Stamoulis Christiana | EVP, CFO | F - Tax | $68.17 | -11.6K | 117.5K | -9% | -$790.0K | |
| D | 2025-07-07 | 2025-07-02 | INCY | Denton Sheila A. | EVP, GC | M - OptEx | $58.06 | +599 | 27.1K | +2% | +$34.8K |
| D | 2025-07-07 | 2025-07-02 | INCY | Denton Sheila A. | EVP, GC | S - Sale+OE | $68.61 | -599 | 26.5K | -2% | -$41.1K |
| 2025-07-07 | 2025-07-02 | INCY | Flannelly Barry P | EVP, General Manager US | F - Tax | $68.17 | -9,055 | 50.6K | -15% | -$617.3K | |
| 2025-07-07 | 2025-07-03 | INCY | Flannelly Barry P | EVP, General Manager US | S - Sale | $68.15 | -10.9K | 39.7K | -22% | -$743.0K | |
| 2025-07-07 | 2025-07-02 | INCY | Stein Steven H | EVP, Chief Medical Off | F - Tax | $68.17 | -12.7K | 112.4K | -10% | -$866.7K | |
| D | 2025-07-02 | 2025-07-02 | INCY | Meury William | CEO, Dir, Pres | A - Grant | $0.00 | +36.1K | 36.1K | New | $0 |
| 2025-07-02 | 2025-06-30 | INCY | HARRIGAN EDMUND | Dir | A - Grant | $68.10 | +367 | 20.3K | +2% | +$25.0K | |
| 2025-07-02 | 2025-06-30 | INCY | Clancy Paul J | Dir | A - Grant | $68.10 | +361 | 22.9K | +2% | +$24.6K | |
| 2025-07-02 | 2025-06-30 | INCY | Issa Mohamed Khairie | EVP, Head of US Oncology | A - Grant | $0.00 | +27.8K | 76.5K | +57% | $0 | |
| MI | 2025-07-02 | 2025-06-30 | INCY | Baker Brothers Life Sciences LP | Dir, 10% | A - Grant | $0.00 | +984 | 28.19M | +0.0% | $0 |
| D | 2025-06-30 | 2025-06-26 | INCY | Hoppenot Herve | Special Advisor to the CEO, Dir | A - Grant | $0.00 | +6,016 | 569.6K | +1% | $0 |
| D | 2025-06-12 | 2025-06-10 | INCY | BRAWLEY OTIS W | Dir | A - Grant | $0.00 | +2,518 | 11.3K | +29% | $0 |
| D | 2025-06-12 | 2025-06-10 | INCY | FOUSE JACQUALYN A | Dir | A - Grant | $0.00 | +2,518 | 19.3K | +15% | $0 |
| D | 2025-06-12 | 2025-06-10 | INCY | Schaffert Susanne | Dir | A - Grant | $0.00 | +2,518 | 7,389 | +52% | $0 |
| D | 2025-06-12 | 2025-06-10 | INCY | Schaffert Susanne | Dir | F - Tax | $70.07 | -849 | 4,871 | -15% | -$59.5K |
| D | 2025-06-12 | 2025-06-10 | INCY | HARRIGAN EDMUND | Dir | A - Grant | $0.00 | +2,518 | 20.0K | +14% | $0 |
| DMI | 2025-06-12 | 2025-06-10 | INCY | Baker Brothers Life Sciences LP | Dir, 10% | A - Grant | $0.00 | +5,036 | 28.19M | +0.0% | $0 |
| D | 2025-06-12 | 2025-06-10 | INCY | Clancy Paul J | Dir | A - Grant | $0.00 | +2,518 | 22.6K | +13% | $0 |
| D | 2025-06-12 | 2025-06-10 | INCY | High Katherine A | Dir | A - Grant | $0.00 | +2,518 | 13.3K | +23% | $0 |
| D | 2025-06-12 | 2025-06-10 | INCY | BIENAIME JEAN JACQUES | Dir | A - Grant | $0.00 | +2,518 | 20.8K | +14% | $0 |
| D | 2025-06-05 | 2025-06-03 | INCY | Denton Sheila A. | EVP, GC | S - Sale+OE | $68.00 | -1,795 | 26.5K | -6% | -$122.1K |
| D | 2025-06-05 | 2025-06-03 | INCY | Denton Sheila A. | EVP, GC | M - OptEx | $58.06 | +1,795 | 28.3K | +7% | +$104.2K |
| M | 2025-06-03 | 2025-05-30+ | INCY | Tray Thomas | Principal Accounting Off | S - Sale | $65.38 | -1,614 | 22.0K | -7% | -$105.5K |
| M | 2025-04-03 | 2025-04-01 | INCY | SWAIN PAULA J | EVP, Human Resources | A - Grant | $0.00 | +22.1K | 107.3K | +26% | $0 |
| 2025-04-03 | 2025-04-01 | INCY | Hoppenot Herve | COB, CEO, Dir, Pres | A - Grant | $0.00 | +66.9K | 563.6K | +13% | $0 | |
| M | 2025-04-03 | 2025-04-01 | INCY | Stamoulis Christiana | EVP, CFO | A - Grant | $0.00 | +37.6K | 129.1K | +41% | $0 |
| M | 2025-04-03 | 2025-04-01 | INCY | Stein Steven H | EVP, Chief Medical Off | A - Grant | $0.00 | +58.2K | 104.2K | +126% | $0 |
| M | 2025-04-03 | 2025-04-01 | INCY | Iyengar Vijay K | EVP, GMAPPS | A - Grant | $0.00 | +22.1K | 52.8K | +72% | $0 |
| 2025-04-03 | 2025-04-01 | INCY | Morrissey Michael James | EVP, Head of Tech. Ops | A - Grant | $0.00 | +4,649 | 86.2K | +6% | $0 | |
| M | 2025-04-03 | 2025-04-01 | INCY | Flannelly Barry P | EVP, General Manager US | A - Grant | $0.00 | +26.1K | 44.7K | +141% | $0 |
| 2025-04-02 | 2025-03-31 | INCY | HARRIGAN EDMUND | Dir | A - Grant | $60.55 | +363 | 17.4K | +2% | +$22.0K | |
| 2025-04-02 | 2025-03-31 | INCY | Clancy Paul J | Dir | A - Grant | $60.55 | +358 | 20.1K | +2% | +$21.7K | |
| MI | 2025-04-02 | 2025-03-31 | INCY | 667, L.P. | Dir, 10% | A - Grant | $0.00 | +974 | 28.18M | +0.0% | $0 |
| 2025-03-27 | 2025-03-25 | INCY | Trotta Matteo | EVP, GM, Dermatology US | F - Tax | $62.08 | -537 | 9,937 | -5% | -$33.3K | |
| M | 2025-03-18 | 2025-03-14 | INCY | Flannelly Barry P | EVP, General Manager US | S - Sale | $67.69 | -19.8K | 33.6K | -37% | -$1.34M |
| D | 2025-03-06 | 2025-03-04 | INCY | Denton Sheila A. | EVP, GC | S - Sale+OE | $69.99 | -599 | 25.8K | -2% | -$41.9K |
| D | 2025-03-06 | 2025-03-04 | INCY | Denton Sheila A. | EVP, GC | M - OptEx | $58.06 | +599 | 26.4K | +2% | +$34.8K |
| D | 2025-02-28 | 2025-02-26 | INCY | Denton Sheila A. | EVP, GC | M - OptEx | $58.06 | +9,574 | 39.9K | +32% | +$555.9K |
| DM | 2025-02-28 | 2025-02-26 | INCY | Denton Sheila A. | EVP, GC | S - Sale+OE | $74.07 | -14.1K | 25.8K | -35% | -$1.04M |
| 2025-02-03 | 2025-01-31 | INCY | Heeson Lee | EVP, Head of Incyte Intl | A - Grant | $0.00 | +6,331 | 32.8K | +24% | $0 | |
| 2025-02-03 | 2025-01-31 | INCY | Morrissey Michael James | EVP, Head of Tech. Ops | A - Grant | $0.00 | +10.6K | 81.5K | +15% | $0 | |
| 2025-01-22 | 2025-01-21 | INCY | Morrissey Michael James | EVP, Head of Tech. Ops | F - Tax | $73.47 | -429 | 71.0K | -0.6% | -$31.5K | |
| D | 2025-01-22 | 2025-01-21 | INCY | Stein Steven H | EVP, Chief Medical Off | S - Sale | $72.69 | -12.4K | 67.0K | -16% | -$897.9K |
| 2025-01-17 | 2025-01-15 | INCY | Stamoulis Christiana | EVP, CFO | F - Tax | $72.46 | -3,672 | 91.5K | -4% | -$266.1K | |
| 2025-01-17 | 2025-01-15 | INCY | Morrissey Michael James | EVP, Head of Tech. Ops | F - Tax | $72.46 | -908 | 71.4K | -1% | -$65.8K | |
| 2025-01-17 | 2025-01-15 | INCY | Stein Steven H | EVP, Chief Medical Off | F - Tax | $72.46 | -10.7K | 79.3K | -12% | -$774.7K | |
| 2025-01-17 | 2025-01-15 | INCY | Flannelly Barry P | EVP, General Manager US | F - Tax | $72.46 | -3,158 | 53.4K | -6% | -$228.8K | |
| 2025-01-08 | 2025-01-06 | INCY | Issa Mohamed Khairie | EVP, Head of US Oncology | A - Grant | $0.00 | +48.7K | 48.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations